<DOC>
	<DOCNO>NCT01087398</DOCNO>
	<brief_summary>The purpose study evaluate efficacy side effect donor hematopoietic cell use chemotherapy regimen without total-body irradiation child undergo hematopoietic stem cell transplant Malignant infantile osteopetrosis . The blood stem cell derive either relate donor unrelated umbilical cord blood haploidentical donor .</brief_summary>
	<brief_title>Hematopoietic Stem Cell Transplantation Malignant Infantile Osteopetrosis</brief_title>
	<detailed_description />
	<mesh_term>Osteopetrosis</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<criteria>Diagnosis Osteopetrosis confirm bone biopsy radiographic image Age 5 year old Carbonic Anhydrase II ( CAII ) deficiency osteopetrosis variant Creatinine clearance ≤ 40ml/min/1.73m^2 RTA Bilirubin ≥ 3mg/dL SGPT ≥ 500 U/L Current severe infection Evidence CNS involvement Morbidity blindness deafness</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Osteopetrosis</keyword>
	<keyword>HSCT</keyword>
</DOC>